lamotrigine and ketamine

lamotrigine has been researched along with ketamine in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.70)18.2507
2000's10 (37.04)29.6817
2010's11 (40.74)24.3611
2020's5 (18.52)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Del Bianco, PL; Nicolodi, M; Sicuteri, F1
Anand, A; Berman, RM; Cappiello, A; Charney, DS; Hu, XS; Krystal, JH; Oren, DA1
Shim, SS1
Anand, A; Krystal, JH; Moghaddam, B1
Kalkman, HO1
Brody, SA; Geyer, MA; Large, CH1
Howland, RH1
Cilia, J; Hatcher, P; Jones, DN; Reavill, C1
Deakin, JF; Dursun, SM; Hallak, JE; Lees, J; McKie, S; Williams, SR1
Garcia, R; Hunt, MJ; Kasicki, S; Large, CH1
aan het Rot, M; Charney, DS; Collins, KA; Mathew, SJ; Murrough, JW; Reich, DL1
Cha, DS; Kim, RD; Mansur, RB; McIntyre, RS1
Brammer, M; Doyle, OM; Joules, R; Mehta, MA; O'Daly, OG; Schwarz, AJ; Williams, SC1
de Simoni, S; Doyle, O; Mehta, MA; Schwarz, AJ; Shcherbinin, S; Zelaya, FO1
Chen, CK; Chen, LY; Huang, MC; Lin, SK1
Andrade, C1
Afridi, S; Viana, M1
Chan, MH; Chen, HH; Hsiao, YC; Lee, MY1
Anand, A; Bakal, O; Esa, WAS; Fang, J; Maheshwari, K; Sessler, DI; Turan, A; Xuan, P1
Cubała, WJ; Jakuszkowiak-Wojten, K; Wiglusz, MS; Wilkowska, A1
Abram, SV; Bustillo, JR; Calhoun, VD; Ford, JM; Fryer, SL; Krystal, JH; Lim, KO; Loewy, RL; Mathalon, DH; Preda, A; Roach, BJ; Stuart, BK; van Erp, TGM1
Beckmann, C; Carstens, L; Gärtner, M; Grimm, S; Hertrampf, R; Keicher, C; Meiering, MS; Mennes, M; Weigand, A; Weigner, D; Wunder, A2

Reviews

7 review(s) available for lamotrigine and ketamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antischizophrenic activity independent of dopamine D2 blockade.
    Expert opinion on therapeutic targets, 2002, Volume: 6, Issue:5

    Topics: Amino Acid Transport System X-AG; Animals; Antipsychotic Agents; Brain Chemistry; Dopamine D2 Receptor Antagonists; Drug Design; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Frontal Lobe; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Interneurons; Ketamine; Lamotrigine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, GABA; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Schizophrenia; Symporters; Triazines

2002
Glutamate-modulating drugs & the treatment of mental disorders.
    Journal of psychosocial nursing and mental health services, 2007, Volume: 45, Issue:1

    Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines

2007
A review of FDA-approved treatment options in bipolar depression.
    CNS spectrums, 2013, Volume: 18 Suppl 1

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzhydryl Compounds; Benzodiazepines; Bipolar Disorder; Central Nervous System Stimulants; Depressive Disorder; Dibenzothiazepines; Drug Approval; Drug Combinations; Excitatory Amino Acid Antagonists; Fluoxetine; Humans; Isoindoles; Ketamine; Lamotrigine; Lurasidone Hydrochloride; Modafinil; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Thiazoles; Triazines; United States; United States Food and Drug Administration

2013
Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions.
    The Journal of clinical psychiatry, 2017, Volume: 78, Issue:7

    Topics: Antidepressive Agents; Benzodiazepines; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Ketamine; Lamotrigine; Polymorphism, Genetic; Risk Factors; Triazines

2017
Migraine with prolonged aura: phenotype and treatment.
    Naunyn-Schmiedeberg's archives of pharmacology, 2018, Volume: 391, Issue:1

    Topics: Humans; Ketamine; Lamotrigine; Migraine with Aura; Phenotype; Pilot Projects; Randomized Controlled Trials as Topic; Treatment Outcome; Triazines; Tryptamines

2018
Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review.
    Cells, 2022, 02-12, Volume: 11, Issue:4

    Topics: Animals; Antidepressive Agents; Depression; Humans; Ketamine; Lamotrigine; Psychopharmacology

2022

Trials

8 trial(s) available for lamotrigine and ketamine

ArticleYear
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Archives of general psychiatry, 2000, Volume: 57, Issue:3

    Topics: Adult; Affect; Brief Psychiatric Rating Scale; Cognition Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Glutamates; Humans; Ketamine; Lamotrigine; Male; Mental Disorders; Perceptual Disorders; Placebos; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Triazines; Verbal Learning

2000
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Archives of general psychiatry, 2008, Volume: 65, Issue:2

    Topics: Adult; Anticonvulsants; Awareness; Brain; Brief Psychiatric Rating Scale; Cross-Over Studies; Dissociative Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Frontal Lobe; Glutamic Acid; Gyrus Cinguli; Humans; Image Enhancement; Image Processing, Computer-Assisted; Infusions, Intravenous; Ketamine; Lamotrigine; Magnetic Resonance Imaging; Male; Oxygen; Premedication; Psychoses, Substance-Induced; Receptors, N-Methyl-D-Aspartate; Statistics as Topic; Triazines

2008
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.
    The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:1

    Topics: Adult; Aged; Depression; Drug Interactions; Drug Resistance; Excitatory Amino Acid Antagonists; Female; Hallucinogens; Humans; Injections, Intravenous; Ketamine; Lamotrigine; Male; Middle Aged; Pilot Projects; Placebos; Riluzole; Secondary Prevention; Time Factors; Treatment Outcome; Triazines

2010
Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects.
    Psychopharmacology, 2015, Volume: 232, Issue:21-22

    Topics: Adult; Brain; Dopamine Antagonists; Double-Blind Method; Excitatory Amino Acid Antagonists; Glutamic Acid; Healthy Volunteers; Humans; Ketamine; Lamotrigine; Male; Receptors, N-Methyl-D-Aspartate; Risperidone; Triazines; Young Adult

2015
Lamotrigine for reducing ketamine-induced psychologic disturbances: A pilot randomized and blinded trial.
    Journal of clinical anesthesia, 2021, Volume: 68

    Topics: Analgesics; Anticonvulsants; Humans; Ketamine; Lamotrigine; Pilot Projects; Research Design

2021
Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia.
    Molecular psychiatry, 2022, Volume: 27, Issue:5

    Topics: Glutamates; Hallucinations; Humans; Ketamine; Lamotrigine; Magnetic Resonance Imaging; Receptors, N-Methyl-D-Aspartate; Schizophrenia

2022
Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain.
    Neuropsychobiology, 2023, Volume: 82, Issue:2

    Topics: Anticonvulsants; Brain; Cognition; Emotions; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Ketamine; Lamotrigine

2023
Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023, Volume: 48, Issue:12

    Topics: Anticonvulsants; Brain; Cerebrovascular Circulation; Glutamates; Humans; Ketamine; Lamotrigine

2023

Other Studies

12 other study(ies) available for lamotrigine and ketamine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse.
    International journal of clinical pharmacology research, 1997, Volume: 17, Issue:2-3

    Topics: Acetates; Adult; Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Lamotrigine; Male; Middle Aged; Migraine Disorders; Opioid-Related Disorders; Substance Withdrawal Syndrome; Triazines

1997
Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state?
    Archives of general psychiatry, 2002, Volume: 59, Issue:5

    Topics: Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Ketamine; Lamotrigine; Models, Biological; Neurons; Pyramidal Cells; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synaptic Transmission; Triazines

2002
Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.
    Archives of general psychiatry, 2002, Volume: 59, Issue:7

    Topics: Animals; Dopamine; Glutamates; Humans; Ketamine; Lamotrigine; Models, Animal; Phencyclidine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synaptic Transmission; Triazines

2002
Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice.
    Psychopharmacology, 2003, Volume: 169, Issue:3-4

    Topics: Acoustic Stimulation; Amphetamine; Animals; Anticonvulsants; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Radiation; Drug Interactions; Excitatory Amino Acid Antagonists; Ketamine; Lamotrigine; Male; Mice; Mice, Inbred Strains; Neural Inhibition; Reflex, Startle; Species Specificity; Triazines

2003
(+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:3

    Topics: Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Ketamine; Lamotrigine; Male; Pyridines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Risperidone; Schizophrenia; Sulfonamides; Thiophenes; Triazines

2007
Modulation of high-frequency oscillations associated with NMDA receptor hypofunction in the rodent nucleus accumbens by lamotrigine.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Jul-01, Volume: 32, Issue:5

    Topics: Algorithms; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Electroencephalography; Excitatory Amino Acid Antagonists; High-Frequency Ventilation; Ketamine; Lamotrigine; Male; Membrane Potentials; Microinjections; Motor Activity; Nucleus Accumbens; Rats; Rats, Wistar; Spectrum Analysis; Time Factors; Triazines

2008
Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile.
    Psychopharmacology, 2015, Volume: 232, Issue:21-22

    Topics: Adult; Brain; Brain Mapping; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Excitatory Amino Acid Antagonists; Humans; Ketamine; Lamotrigine; Magnetic Resonance Imaging; Male; Receptors, N-Methyl-D-Aspartate; Risperidone; Triazines; Young Adult

2015
Potential benefit of lamotrigine in managing ketamine use disorder.
    Medical hypotheses, 2016, Volume: 87

    Topics: Adult; Animals; Excitatory Amino Acid Antagonists; Humans; Ketamine; Lamotrigine; Male; Models, Biological; Phencyclidine Abuse; Triazines

2016
Lamotrigine attenuates the motivation to self-administer ketamine and prevents cue- and prime-induced reinstatement of ketamine-seeking behavior in rats.
    Drug and alcohol dependence, 2019, 01-01, Volume: 194

    Topics: Analgesics; Animals; Anticonvulsants; Cues; Drug-Seeking Behavior; Extinction, Psychological; Ketamine; Lamotrigine; Locomotion; Male; Motivation; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration

2019